22.8 C
New York
Sunday, June 14, 2026

Tag: executive

newssourceFORcompanyinformationcontent1marketreleases

Éduc’alcool welcomes Yvan Gendron as Chair of its Board of Directors

The organization continues its evolution and reaffirms its commitment to education and prevention in QuébecMONTRÉAL, June 11, 2026 /CNW/ - Éduc'alcool is pleased to...

Compass Diversified Announces CEO Succession Plan

Co-Founder and Chief Executive Officer Elias Sabo to Retire at Year End

Dana Incorporated Announces Agreement to Combine with Eaton’s Mobility Business, Strengthens Dana’s Position as a Leading Global Powertrain Systems Provider

Creates a premier, global powertrain leader focused on commercial and light vehicles with approximately $11 billion in sales and approximately $1.7 billion adjusted EBITDA...

Regulatory release no. 6 – 2026: New long-term share-based incentive programme

New long-term share-based incentive programme

CDP Announces Transformative Investment to Accelerate Environmental Transparency Worldwide

CDP to become two separate organisations – CDP, a commercial entity backed by Permira, and CDP Foundation, a non-profit, charitable organisation focused on pioneering...

Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India

Greenfield facility in Madhya Pradesh to support 'Make in India' vision and strengthen Haleon's commitment to delivering better everyday healthStrategic oral health-focused site designed...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

APR Expands Global Footprint in the U.S. and UK with Launch of Medicube AGE-R ‘Booster Pro X2’

Strategic rollout across major e-commerce platforms in the U.S. and UK reinforces APR's expanding global beauty device footprint.Sequential launches planned across TikTok Shop and...

NX Group Named Presenting Sponsor of MLB Draft in 2026, 2027 with “2026 MLB Draft Presented by NX” Being Held in Philadelphia This July

- Annual Event to Be Broadcast Nationwide on NBC -TOKYO, June 11, 2026 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. will serve as the presenting...

Regulatory release no. 4 – 2026: Correction. Result of InstallatørGruppen A/S’ Initial Public Offering on Nasdaq Copenhagen

                           

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

ToolGen Opens Advanced Field Testing Facility in Osong, Completing ‘Bench-to-Field’ Commercialization Platform for Global SAF and Industrial Crop Markets

Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization.Enables comprehensive field evaluation of a diversified crop portfolio, including drought...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsExecutive

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers